ci 966 has been researched along with nipecotic acid in 1 studies
| Studies (ci 966) | Trials (ci 966) | Recent Studies (post-2010) (ci 966) | Studies (nipecotic acid) | Trials (nipecotic acid) | Recent Studies (post-2010) (nipecotic acid) |
|---|---|---|---|---|---|
| 14 | 0 | 4 | 308 | 0 | 43 |
| 14 | 0 | 4 | 15 | 0 | 5 |
| Protein | Taxonomy | ci 966 (IC50) | nipecotic acid (IC50) |
|---|---|---|---|
| Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | 5.92 | |
| Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | 8.1516 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 8.5114 | |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | 2.3314 | |
| Sodium- and chloride-dependent betaine transporter | Mus musculus (house mouse) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borden, LA; Branchek, TA; Dhar, TG; Gluchowski, C; Smith, KE; Tyagarajan, S; Weinshank, RL | 1 |
1 other study(ies) available for ci 966 and nipecotic acid
| Article | Year |
|---|---|
Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
Topics: Animals; Binding Sites; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Cell Line; Cloning, Molecular; Drug Design; GABA Antagonists; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Humans; Ligands; Membrane Proteins; Membrane Transport Proteins; Nipecotic Acids; Organic Anion Transporters; Proline; Rats | 1994 |